OCDB: A database collecting genes, miRNAs and drugs for obsessive-compulsive disorder

Database

Volumn 2015, Issue , 2015, Pages

  Privitera, Anna P ^a,b   Distefano, Rosario ^c   Wefer, Hugo A ^d   Ferro, Alfredo ^a   Pulvirenti, Alfredo ^a   Giugno, Rosalba ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d SCIENCE FOR LIFE LABORATORY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; MICRORNA;

CLASSIFICATION; FACTUAL DATABASE; GENETIC DATABASE; GENETICS; HUMAN; INFORMATION PROCESSING; METABOLISM; OBSESSIVE-COMPULSIVE DISORDER;

CENTRAL NERVOUS SYSTEM AGENTS; DATA CURATION; DATABASES, FACTUAL; DATABASES, GENETIC; HUMANS; MICRORNAS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84943176137     PISSN: 17580463     EISSN: None     Source Type: Journal    
DOI: 10.1093/database/bav069     Document Type: Article

References (75)

1. Mataix-Cols, D., Rosario-Campos, M. and Leckman, J. (2005) A multidimensional model of obsessive-compulsive disorder. Am. J. Psychiatry, 162, 228-238.
2. Mataix-Cols, D. (2006) Deconstructing obsessive-compulsive disorder: A multidimensional perspective. Curr. Opin. Psychiatry, 19, 84-89.
3. Geller, D., Biederman, J., Jones, J. et al. (1998) Obsessive-compulsive disorder in children and adolescents: A review. Harv. Rev. Psychiatry, 5, 260-273.
4. Rosario-Campos, M., Leckman, J., Mercadante, M. et al. (2001) Adults withearly-onset obsessive-compulsive disorder. Am. J. Psychiatry, 158, 1899-1903.
5. Rasmussen, S. and Eisen, J. (1992) The epidemiology and clinical features of obsessive-compulsive disorder. Psychiatr. Clin. North Am., 15, 743-758.
6. Kessler, R., Berglund, P., Demler, O. et al. (2005) Lifetime prevalence andage-of-onset distributions of dsm-iv disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry, 62, 593-602.
7. World Health Organization. (2010) International statistical classification of diseases and related health problems, 10th revision. Geneva, World Health Organization. Available: Http://apps.who.int/classifications/icd10/browse/2010/en#/I20-I25 Accessed 28 Jan 2011.
8. American Psychiatric Association. (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Rev. American Psychiatric Association ISBN: 978-0-89042-025-6.
9. American Psychiatric Association. (2013): Diagnostic and Statistical Manual of Mental Disorders (Fifth ed.). Arlington, VA: American Psychiatric Publishing. ISBN 978-0-89042-555-8.
10. American Psychiatric Association. (2013) Highlights of Changes from DSM-IV-TR to DSM-5. Arlington, VA: American Psychiatric Association.
11. Van-Ameringen, M., Patterson, B. and Simpson, W. (2014) DSM-5 obsessive-compulsive and a related disorders: Clinical implications of new criteria. Depress. Anxiety, 31, 487-493.
12. Murray, C. and Lopez, A. (1996) Global Burden of Disease: A Comprehensive Assessment of Mortality and Morbidity From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. The lancet, 349, 9064, 1498-1504, 1997.
13. Pitman, R. (1984) Janet's obsessions and psychasthenia: A synopsis. Psychiatr. Q., 56, 291-314.
14. Hanna, G., Veenstra-VanderWeele, J., Cox, N. et al. (2002) Genome-wide linkage analysis of families with obsessive compulsive disorder ascertained through pediatric probands. Am. J. Med. Genet., 114, 541-552.
15. Willour, V., Yao Shugart, Y., Samuels, J. et al. (2004) Replication study supports evidence for linkage to 9p24 in obsessivecompulsive disorder. Am. J. Hum. Genet., 75, 508-513.
16. Nestadt, G., Samuels, J. and Riddle, M. (2000)A family study of obsessive-compulsive disorder. Arch.Gen. Psychiatry, 57, 358-363.
17. do Rosario-Campos, M.C., Leckman, J., Curi, M. et al. (2005) A family study of early-onset obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet., 136B, 92-97.
18. Hanna, G., Himle, J., Curtis G. et al. (2005) A family study of obsessive-compulsive disorder with pediatric probands. Am. J. Med. Genet. B Neuropsychiatr. Genet., 134B, 13-19.
19. Bienvenu, O., Samuels, J., Riddle, M. et al. (2000) The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biol. Psychiatry, 48, 287-293.
20. Grados, M., Riddle, M., Samuels, J. et al. (2001) The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: The Hopkins ocd family study. Biol. Psychiatry, 50, 559-565.
21. Hettema, J., Neale, M. and Kendler, K. (2001) A review and metaanalysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry, 158, 1568-1578.
22. Veenstra-VanderWeele, J., Kim, S., Gonen, D. et al. (2001) Genomic organization of the slc1a1/eaac1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol. Psychiatry, 6, 160-167.
23. Arnold, P., Sicard, T., Burroughs, E. et al. (2006) Glutamate transporter gene slc1a1 associated with obsessive-compulsive disorder. Arch. Gen. Psychiatry, 63, 769-776.
24. Kanai, Y., Hediger, M. (2004) The glutamate/neutral amino acid transporter family slc1: Molecular, physiological and pharmacological aspects. Pflugers Arch., 447, 469-479.
25. Bonelli, R. and Cummings, J. (2007) Frontal-subcortical circuitry and behavior. Dialogues Clin. Neurosci., 9, 141-151.
26. Bloch, M. and Pittenger, C. (2010) The genetics of obsessive-compulsive disorder. Curr. Psychiatry Rev., 6, 91-103.
27. McDougle, C., Epperson, C., Price, L. et al. (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (slc6a4) and obsessive compulsive disorder. Mol. Psychiatry, 3, 270-273.
28. Lei, X., Chen, C., He, Q. et al. (2012) Sex determines which section of the slc6a4 gene is linked to obsessive-compulsive symptoms in normal Chinese college students. J. Psychiatr. Res., 46, 1153-1160.
29. Frisch, A., Michaelovsky, E., Rockah, R. et al. (2000) Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur. Neuropsychopharmacol., 10, 205-209.
30. Meira-Lima, I., Shavitt, R. and Miguita, K. (2004) Association analysis of the catechol-o-methyltransferase (comt), serotonin transporter (5-htt) and serotonin 2a receptor (5ht2a) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav., 3, 75-79.
31. Alonso, P., Gratacòs, M., Menchon, J. et al. (2008) Genetic susceptibility to obsessive-compulsive hoarding: The contribution of neurotrophic tyrosine kinase receptor type 3 gene. Genes Brain Behav., 7, 778-785.
32. Ozomaro, U., Cai, G., Kajiwara, Y. et al. (2013) Characterization of slitrk1 variation in obsessive-compulsive disorder. PLoS One, 8, e70376.
33. Sun, B. and Tsao, H. (2008) Small RNAs in development and disease. J. Am. Acad. Dermatol., 59, 725-737.
34. Malan-Muller, S., Hemmings, S. and Seedat, S. (2013) Big effects of small RNAs: A review of microRNAs in anxiety. Mol. Neurobiol., 47, 726-739.
35. Kawaji, H. and Hayashizaki, Y. (2008) Exploration of small RNAs. PLoS Genet., 4, 220.
36. Filipowicz, W., Bhattacharyya, S. and Sonenberg, N. (2008) Mechanisms of posttranscriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet., 9, 102-114.
37. Muiños-Gimeno, M., Guidi, M., Kagerbauer, B. et al. (2009) Allele variants in functional microRNA target sites of the neurotrophin-3receptor gene (ntrk3) as susceptibility factors for anxiety disorders. Hum. Mutat., 30, 1062-1071.
38. Basoglu, M., Lax, T., Kasvikis, Y. et al. (1988) Predictors of improvement in obsessive-compulsive disorder. J. Anxiety Disord., 2, 299-317.
39. Bandelow, B., Zohar, J., Hollander, E. et al. (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessivecompulsive and post-traumatic stress disorders-first revision. World J. Biol. Psychiatry, 9, 248-312.
40. Kellner, M. (2010) Drug treatment of obsessive-compulsive disorder. Dialogues Clin. Neurosci., 12, 187-197.
41. Franklin, M. and Foa, E. (2011) Treatment of obsessive compulsive disorder. Annu. Rev. Clin. Psychol., 7, 229-243.
42. De Berardis, D., Serroni, N., Marini, S. et al. (2012) Agomelatine augmentation of escitalopram therapy in treatment resistant obsessive-compulsive disorder: A case report. Case Rep. Psychiatry, 2012, 642752.
43. De Berardis, D., Di Iorio, G., Acciavatti, T. et al. (2011) The emerging role of melatonin agonists in the treatment of major depression: Focus on agomelatine. CNS Neurol. Disord. Drug Targets, 10, 119-132.
44. Goodman, W., Price, L., Rasmussen, S. et al. (1989) Theyalebrown obsessive compulsive scale. i. development, use, and reliability. Arch. Gen. Psychiatry, 46, 1006-1011.
45. Macleod, M.R. (2002) Pubmed: Http://www.pubmed.org. J. Neurol. Neurosurg. Psychiatry, 73, 746.
46. Maglott, D., Ostell, J., Pruitt, KD. et al. (2011) Entrez Gene: Genecentered information at NCBI. Nucleic Acids Res., 39, D52-D57.
47. Povey, S., Lovering, R., Bruford, E. et al. (2001) The hugo gene nomenclature committee (hgnc). Hum. Genet., 109, 678-680.
48. Sherry, S., Ward, M., Kholodov, M. et al. (2001) dbsnp: The ncbi database of genetic variation. Nucleic Acids Res., 29, 308-311.
49. Knox, C., Law, V., Jewison, T. et al. (2011) Drugbank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res., 5(Database issue), 1035-1041.
50. Griths-Jones, S., Grocock, R., van Dongen, S. et al. (2006) mirbase: MicroRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 34(Database issue), 140-144.
51. Bolton, E., Wang, Y., Thiessen, S. et al. (2008) PubChem: Integrated platform of small molecules and biological activities. Chapter 12 IN Wheeler RA and Spellmeyer DC, eds. Annual Reports in Computational Chemistry, Volume 4. Oxford, UK: Elsevier, 4, 217-241.
52. Huang, D.W., Sherman, B.T. and Lempicki, R.A. (2008) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat. Protoc., 4, 44-57.
53. Huang, D.W., Sherman, B.T. and Lempicki, R.A. (2009) Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
54. Wang, J., Lu, M., Qiu, C. et al. (2010) TransmiR: A transcription factor-microRNA regulation database. Nucleic Acids Res., 38(Database issue), D119-D122.
55. Kanehisa, M., Goto, S., Sato, Y. et al. (2014) Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res., 42, D199-D205.
56. Kanehisa, M. and Goto, S. (2002) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, 27-30.
57. Wu, T.-J., Schriml, L.M., Chen, Q.-R. et al. (2015) Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis. Database (Oxford), 2015:bav032.
58. Degtyarenko, K., de Matos, P., Ennis, M. et al. (2008) ChEBI: A database and ontology for chemical entities of biological interest. Nucleic Acids Res., 36(Database issue), D344-D350.
59. Lewis, B., Shih, I., Jones-Rhoades, M. et al. (2003) Prediction of mammalian microRNA targets. Cell, 115, 787-798.
60. Hsu, S., Lin, F., Wu, W. et al. (2011) mirtarbase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Res., 39(Database issue), 163-169.
61. John, B., Enright, A., Aravin, A. et al. (2004) Human microRNA targets. PLoS Biol., 2, 363.
62. Alaimo, S., Pulvirenti, A., Giugno, R. et al. (2013) Drug-target interaction prediction through domain-tuned network-based inference. Bioinformatics, 29, 2004-2008.
63. Kim, J., Kim, H., Yoon, Y. et al. (2015) LGscore: A method to identify disease-related genes using biological literature and Google data. J. Biomed. Inform., 54, 270-282.
64. Billett, E., Richter, M., Sam, F. et al. (1998) Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr. Genet., 8, 163-169.
65. Muiños-Gimeno, M., Espinosa-Parrilla, Y., Guidi, M. et al. (2011) Human microRNAs mir-22, mir-138-2, mir-148a, and mir-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol. Psychiatry, 69, 526-533.
66. Childs, E., Hoho, C., Deckert, J. et al. (2008) Association between adora2a and drd2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology, 33, 2791-2800.
67. Pasquini, M., Garavini, A. and Biondi, M. (2005) Nicotine augmentation for refractory obsessive-compulsive disorder. A case report. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 157-159.
68. Tizabi, Y., Louis, V.A., Taylor, C.T. et al. (2002) Effect of nicotine on quinpirole-induced checking behavior in rats: Implications for obsessive-compulsive disorder. Biol Psychiatry, 51, 164-171.
69. Donner, J., Pirkola, S., Silander, K. et al. (2008) An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol. Psychiatry, 64, 672-680.
70. Zhang, B., Kirov, S. and Snoddy, J. (2005) Webgestalt: An integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res., 33, 741-748.
71. Baranczyk-Kuzma, A., Kuzma, M. and Gutowicz, M. (2004) Glutathione s-transferase pi as a target for tricyclic antidepressants in human brain. Acta Biochim. Pol., 51, 207-212.
72. Hassan, W., Silva, C., Mohammadzai, I. et al. (2014) Association of oxidative stress to the genesis of anxiety: Implications for possible therapeutic interventions. Curr. Neuropharmacol., 12, 120-139.
73. Fa, M., Xia, L., Anunu, R. et al. (2014) Stress modulation of hippocampal activity - spotlight on the dentate gyrus. Neurobiol. Learn. Mem., 112, 53-60.
74. Baudry, A., Mouillet-Richard, S., Schneider, B. et al. (2010) mir-16 targets the serotonin transporter: A new facet for adaptive responses to antidepressants. Science, 329, 1537-1541.
75. Espinosa-Parrilla, Y. and Muiños-Gimeno, M. (2011) MicroRNAmediated regulation and the genetic susceptibility to anxiety disorders. In: Anxiety Disorders, Prof. Vladimir Kalinin (ed). ISBN: 978-953-307-592-1, InTech, DOI: 10.5772/21702.